Bruce E. Johnson
0000-0002-5252-3677
Publication & Citation Trends
Publications
0 total
Molecular characterization of HER2-negative breast cancers reveals a distinct patient subgroup with 17q12 deletion and heterozygous loss of ERBB2
Cited by 4
Semantic Scholar
Abstract P4-03-20: Molecular characterization of estrogen receptor (ER)+/HER2- breast cancer unveils a biologically and clinically distinct entity with ERBB2 hemizygous deletion (ERBB2del)
Cited by 0
Semantic Scholar
Abstract P3-09-19: Tumor genomics in young patients with metastatic breast cancer
Cited by 0
Semantic Scholar
A cellular and spatial atlas of TP53-associated tissue remodeling defines a multicellular tumor ecosystem in lung adenocarcinoma
Cited by 5
Semantic Scholar
Author Correction: A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features OA
Cited by 0
Semantic Scholar
A spatial cell atlas of neuroblastoma reveals developmental, epigenetic and spatial axis of tumor heterogeneity OA
Cited by 27
Semantic Scholar
Abstract PO1-14-10: Comprehensive clinicogenomic characterization of inflammatory breast cancer
Cited by 0
Semantic Scholar
Clinicogenomic characterization of inflammatory breast cancer OA
Cited by 1
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(461)
Cancer Genomics and Diagnostics
(183)
Lung Cancer Research Studies
(178)
Immunotherapy and Immune Responses
(135)
Cancer Immunotherapy and Biomarkers
(118)
Affiliations
The Wistar Institute
AstraZeneca (United Kingdom)
Broad Institute
Boston University
Northwestern University